DakoCytomation to market LightUp's assays:
This article was originally published in Clinica
Executive Summary
LightUp Technologies has granted Danish company, DakoCytomation co-exclusive rights to market and sell its line of ReSSQ infectious disease diagnostic products in Europe. The two companies will also collaborate on developing other products based on LightUp's proprietary assay technology. Huddinge, Sweden-based LightUp says its range of infectious disease diagnostics, based on nucleic acid detection, enables simpler and more accurate identification and quantification of disease generating organisms. The LightUp probe, inherent to the system, is designed to work with real-time PCR and can have several applications, including gene mapping and disease diagnostics.
You may also be interested in...
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections
In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.